Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction.

Villa A, Arnold R, Sánchez PL, Gimeno F, Ramos B, Cantero T, Fernández ME, Sanz R, Gutiérrez O, Mota P, García-Frade J, San Román JA, Fernández-Avilés F; Terapia Celular Aplicada al Miocardio Research Group.

Am J Cardiol. 2009 Jun 15;103(12):1651-6. doi: 10.1016/j.amjcard.2009.02.011. Epub 2009 Apr 16.

PMID:
19539071
2.

A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.

Rathore S, Kinoshita Y, Terashima M, Katoh O, Matsuo H, Tanaka N, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T.

EuroIntervention. 2010 Feb;5(7):841-6.

PMID:
20142201
3.

Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.

Stone GW, Parise H, Witzenbichler B, Kirtane A, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Lansky AJ, Mehran R.

J Am Coll Cardiol. 2010 Nov 2;56(19):1597-604. doi: 10.1016/j.jacc.2010.08.608. Epub 2010 Oct 1.

4.

In vivo virtual histology intravascular ultrasound comparison of neointimal hyperplasia within drug-eluting- versus bare metal stents.

Wakabayashi K, Mintz G, Delhaye C, Choi YJ, Doh JH, Ben-Dor I, Gaglia M Jr, Pakala R, Suddath W, Satler L, Kent K, Pichard A, Weissman N, Waksman R.

J Invasive Cardiol. 2011 Jul;23(7):262-8.

5.

Intimal hyperplasia by optical coherence tomography after BMS and DES implantation in the same artery.

Karantalis V, Davlouros P, Alexopoulos D.

Int J Cardiol. 2011 May 5;148(3):e66-7. doi: 10.1016/j.ijcard.2009.03.009. Epub 2009 Mar 29.

PMID:
19329194
6.

Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).

Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G; PRODIGY Investigators.

JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.

7.

Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosis.

Ribamar Costa J, Sousa AG, Moreira A, Alves da Costa R, Cano MN, Maldonado G, Campos Neto C, Jardim C, Pavanello R, Sousa JE.

EuroIntervention. 2009 Sep;5(4):448-53.

PMID:
19755332
8.

Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent.

Ge H, Zhang Q, Zhou W, He Q, Han ZH, He B.

J Zhejiang Univ Sci B. 2010 Aug;11(8):553-60. doi: 10.1631/jzus.B1001002.

9.

Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial.

Kelbaek H, Thuesen L, Helqvist S, Clemmensen P, Kløvgaard L, Kaltoft A, Andersen B, Thuesen H, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Lassen JF; DEDICATION Investigators.

Circulation. 2008 Sep 9;118(11):1155-62. doi: 10.1161/CIRCULATIONAHA.107.758698. Epub 2008 Aug 25.

10.
11.

In-stent restenosis in bare metal stents versus sirolimus-eluting stents after primary coronary intervention for acute myocardial infarction and subsequent transcoronary transplantation of autologous stem cells.

Steinwender C, Hofmann R, Kypta A, Kammler J, Kerschner K, Grund M, Sihorsch K, Gabriel C, Leisch F.

Clin Cardiol. 2008 Aug;31(8):356-9. doi: 10.1002/clc.20235.

12.
13.

Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy.

Maehara A, Mintz GS, Lansky AJ, Witzenbichler B, Guagliumi G, Brodie B, Kellett MA Jr, Parise H, Mehran R, Stone GW.

Circulation. 2009 Nov 10;120(19):1875-82. doi: 10.1161/CIRCULATIONAHA.109.873893. Epub 2009 Oct 26.

14.

Safety and effectiveness of drug eluting stent in patients with ST elevation myocardial infarction undergoing primary angioplasty.

Romano M, Buffoli F, Tomasi L, Corrado L, Ferrari MR, Zanini R.

Catheter Cardiovasc Interv. 2008 May 1;71(6):759-63. doi: 10.1002/ccd.21529.

PMID:
18412066
15.

Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.

Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K.

J Cardiol. 2014 Nov;64(5):377-83. doi: 10.1016/j.jjcc.2014.02.020. Epub 2014 Mar 28.

16.

Primary percutaneous coronary intervention for acute myocardial infarction: long-term outcome after bare metal and drug-eluting stent implantation.

Kukreja N, Onuma Y, Garcia-Garcia H, Daemen J, van Domburg R, Serruys PW.

Circ Cardiovasc Interv. 2008 Oct;1(2):103-10. doi: 10.1161/CIRCINTERVENTIONS.108.787762. Epub 2008 Sep 3.

17.

Mechanisms of non-fatal stent-related myocardial infarction late following coronary stenting with drug-eluting stents and bare metal stents. Insights from optical coherence tomography.

Davlouros PA, Karantalis V, Xanthopoulou I, Mavronasiou E, Tsigkas G, Toutouzas K, Alexopoulos D.

Circ J. 2011;75(12):2789-97. Epub 2011 Sep 14.

18.

Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.

Vink MA, Van Nooijen FC, Laarman GJ, Suttorp MJ, Tijssen JG, Slagboom T, Patterson MS, Van Der Schaaf RJ, Kiemeneij F, Amoroso G, Dirksen MT.

Am J Cardiol. 2011 Nov 1;108(9):1214-9. doi: 10.1016/j.amjcard.2011.06.034. Epub 2011 Aug 23.

PMID:
21864813
20.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).

Ormiston J, Webster M, Stewart J, Vrolix M, Whitbourn R, Donohoe D, Knape C, Lansky A, Attizzani GF, Fitzgerald P, Kandzari DE, Wijns W.

JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.

Supplemental Content

Support Center